NIM
DNLI icon

NEOS Investment Management’s Denali Therapeutics DNLI Stock Holding History

NEOS Investment Management’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,174
Closed -$212K – 638
2025
Q2 		$212K Hold
15,174
– – ﹤0.01% 610
2025
Q1 		$206K Buy
+15,174
New +$291K ﹤0.01% 585
2024
Q4 		– Sell
-21,648
Closed -$631K – 597
2024
Q3 		$631K Hold
21,648
– – 0.02% 460
2024
Q2 		$503K Hold
21,648
– – 0.02% 452
2024
Q1 		$444K Buy
+21,648
New +$407K 0.03% 409

Other funds holding DNLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

NEOS Investment Management's DNLI Position: Q3 2025 in Review

NEOS Investment Management sold out of Denali Therapeutics (DNLI) in Q3 2025, closing a stake of 15,174 shares — an estimated $212K sold.

NEOS Investment Management first reported a position in DNLI in Q1 2024 and held it in 5 quarters. The position peaked at $631K in Q3 2024. 240 funds tracked by Wall St. Rank hold DNLI as of Q3 2025.

  • NEOS Investment Management reported no remaining Denali Therapeutics position as of Q3 2025 after selling out during the quarter.
  • NEOS Investment Management sold 15,174 Denali Therapeutics shares in Q3 2025, an estimated $212K.
  • NEOS Investment Management first reported a position in Denali Therapeutics in Q1 2024 and held it in 5 quarters.
  • NEOS Investment Management's Denali Therapeutics position peaked at $631K in Q3 2024.
  • 240 funds tracked by Wall St. Rank held Denali Therapeutics as of Q3 2025.

Based on NEOS Investment Management's 13F filing for Q3 2025, filed 7 Nov 2025.